Patient Conditions/Disease States

AMCP Submits Comments in Response to PQA Endorsement Consideration of Two New Performance Measures: Concurrent Use of Opioids and Benzodiazepines and Adherence to Non-Infused Disease Modifying Agents Use to Treat Multiple Sclerosis

The Academy of Managed Care Pharmacy (AMCP) thanks the Pharmacy Quality Alliance (PQA) for the opportunity to provide comments in response to the Call for Comments on PQA Endorsement Consideration of Two New Performance Measures.
Patient Conditions/Disease States, Rare Diseases

PRIME Partners With AGA and AMCP on Hepatitis C Virus and Inflammatory Bowel Disease Educational Initiative

Press Release: PRIME Education, Inc. (PRIME), the American Gastroenterological Association (AGA), and the Academy of Managed Care Pharmacy (AMCP), are pleased to announce a groundbreaking initiative in collegial learning between payers and providers to improve treatment decision-making in chronic and costly gastroenterological (GI) diseases.
Patient Conditions/Disease States, Rare Diseases